Cantourage Group SE Logo

Cantourage Group SE

ISIN

DE000A3DSV01

Ticker

HIGH

Sector

Consumer Staples

Sub-Industry

Tobacco

Country

Germany

Year Founded

2019

About Cantourage Group SE

Company Description

Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.

Served Area

Europe

Headquarters

Feurigstraße 54
10827, Berlin
Germany

Insider Trades

Date Trading entity / Person Association Trade type Volume
18.07.2024 PiFriva Verwaltungs- und Beteiligungs-GmbH Close relation Sell EUR 140,000.00
06.06.2024 HOFY4 GmbH Close relation Sell EUR 345,000.00
27.05.2024 HOFY4 GmbH Close relation Sell EUR 7,400.00
17.05.2024 HOFY4 GmbH Close relation Sell EUR 140,000.00
17.05.2024 HOFY4 GmbH Close relation Sell EUR 1,080.00
21.02.2024 HOFY4 GmbH Close relation Sell EUR 63,205.88
14.02.2024 Think.Health Projekt M GmbH & Co. KG Close relation Sell EUR 82,415.57
14.02.2024 Think.Health Projekt M GmbH & Co. KG Close relation Sell EUR 4,005.00
07.09.2023 CDXX Vermögens- und Verwaltungs GmbH Close relation Sell EUR 105,490.00
17.08.2023 HOFY4 GmbH Close relation Sell EUR 40,023.24

Capital Markets Information

ISIN

DE000A3DSV01

LEI

3912003NCTLO6YHA9V48

Industry

Tobacco

Sub-Industry

Tobacco

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.